References
- 1. Thavani V. Rational use of medicines: Achievements and challenges. Indian J Pharmacol. 2010; 42(2): 63-4.
- 2. Stefanović S, Novokmet SS, Milivojević N, Janković SM. Non-steroidal antiinflammatory drugs utilization at general and endocrine surgery departments of Clinical Center „Kragujevac“ in Kragujevac. Medicinski časopis. 2012; 46(1): 14-8.
- 3. Ng Siew C, Chan Francis KL. NSAID-induced gastrointestinal and cardiovascular injury. Current Opinion in Gastroenterology. 2010; 26(6): 611-7.
- 4. Mijatović V, Ćalasan J, Horvat O, Sabo A, Tomić Z, Radulović V. Consumption of non-steroidal anti-inflammatory drugs in Serbia:a comparison with Croatia and Denmark during 2005-2008. Eur J Clin Pharmacol. 2011; 67: 203-7.
- 5. Vlahovic-Palcevski V, Wattermark B, Bergman U. Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm). Eur J Clin Pharmacol. 2002; 58: 209-14.
- 6. Inotai A, Hankó B, Mészarós Á. Trends in non-steroidal anti-inflammatory drug market in six Central-Eastern Europian countries based on retail information. Pharmacoepidemiology and drug safety. 2010; 19: 183-90.
- 7. Ćalasan J, Mijatović V, Horvat O, Varga J, Sabo A, Stilinović N. The outpatient utilization of non-steroidal anti-inflammatory drugs in South Bačka District, Serbia. Ind J Clin Pharmacol. 2011; 33: 246-51.
- 8. Fosbøl EL, Gislason GH, Jacobsen S, Abildstrom SZ, Hansen ML, Schramm TK, Folke F, Sørensen R, Rasmussen JN, Køber L, Madsen M, Torp-Pedersen C. The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidemiol Drug Saf. 2008; 17(8): 822-33
- 9. Laine L. Gastrointestinal effects of NSAIDs and coxibs. J Pain Symptom Manage.2003; 25 (2 Suppl): S32-40.
- 10. Rahme E, Joseph L, Kong SX, Watson DJ, LeLorier J. Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population. Arthritis Rheum. 2000; 43(4): 917-24.
- 11. Bloom SB. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis. Am J Med 1986; 84 (Suppl 2A): 20-4.
- 12. World Health Organization Collaborating Centre for Drug Statistics Methodology. About the ATC/DDD system. Available at: http://www.whocc.no/atc_ddd_index/ Accessed 1.10.2013.
- 13. Sweetman SC, ed. Martindale: the complete drug reference 36. London: Pharmaceutical Press, 2009. (CD-ROOM).
- 14. Staa TP, Rietbrock S, Setakis E, Leufkens HGM. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction? Journal of internal medicine. 2008; 264: 481-92.
- 15. Gupta M, Malhotra S, Jain S, Aggarwal A, Pandhi P. Pattern of prescription of non-steroidal anti-inflammatory drugs in orthopedic outpatient clinic of a north Indian tertiary care hospital. Indian J Pharmacol 2005; 37: 404-5.
- 16. Paul A.D. Chauhan C.K. Study of usage pattern of nonsteroidal anti-inflammatory drugs (NSAIDs) among different practice categories in Indian clinical setting. Eur J Clin Pharmacol. 2005; 60: 889-92.
- 17. Aqil M, Bhadana V, Alam MS, Pillai KK, Kapur P. Medicine utilization review at a university teaching hospital in New Delhi. J Pharm Bioallied Sci. 2012; 4(3): 202-6.
- 18. Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Salvo F, Nicotra F, Sturkenboom M, Perez-Gutthann S. Myocardial infarction and individual non-steroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacoepidemiol Drug Saf 2013; 22(6): 559-70.
- 19. Bergman U, Andersen M, Vaccheri A, Bjerrum L, Wattermark B, Montanaro N. Deviations from evidence-based prescribing of non-steroidan anti-inflamatory drugs in three Europian regions. Eur J Clin Pharmacol. 2000; 56: 269-72.